Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| James Ford | M | - | 29 anni | |
| David Redfern | M | 57 | 30 anni | |
| Sally Jackson | F | - | 23 anni | |
| Timothy Woodthorpe | M | - | 24 anni | |
| Graham Rivers | M | - | 26 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Gary Jacob | M | 77 |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 10 anni |
| Craig C. Talluto | M | - |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 8 anni |
| Bernard Denoyer | M | 77 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 9 anni |
| Robert Carr | M | - | 26 anni | |
| Murray Stewart | M | 63 | 17 anni | |
| Christopher Viehbacher | M | 64 | 20 anni | |
| Julian Heslop | M | 70 | 13 anni | |
| Alex Howarth | M | 55 | 10 anni | |
| Michèle Barzach | M | - | 7 anni | |
| John David Coombe | M | 79 | 5 anni | |
| Richard Sykes | M | 79 | 7 anni | |
| Ian Maurice Gray Prosser | M | 81 | 9 anni | |
| William Louv | M | - | 21 anni | |
| John Brancaccio | M | 76 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 9 anni |
| Jean-Pierre Garnier | M | 75 | 8 anni | |
| Peter Traber | M | 69 | 3 anni | |
| Lawson Macartney | M | 66 | 12 anni | |
| Roger Connor | M | - | 24 anni | |
| Michael Owen | M | 73 | 9 anni | |
| Song Gao | M | 52 | 22 anni | |
| John B. Elliot | M | 72 | 5 anni | |
| Graham Ross | M | 64 | 11 anni | |
| David Wheadon | M | 66 | 5 anni | |
| Denis Brodsky | M | 53 | 5 anni | |
| Anne Brindley | M | 59 | 3 anni | |
| Tina Russell | F | - | 1 anni | |
| David M. Pernock | M | 69 | 16 anni | |
| Robert J. DiVasto | M | 68 | 2 anni | |
| Peter John Murray | M | - | - | |
| Carol Ashe | F | 66 | 13 anni | |
| Duncan Learmouth | M | - | - | |
| Thierry Loriot | M | - | - | |
| Jay C. Strum | M | - | 14 anni | |
| Daniel G. Marquess | M | 55 | 4 anni | |
| Lini Pandite | M | 65 | 14 anni | |
| Edgar Cale | M | 60 | 21 anni | |
| Deborah Waterhouse | F | 57 | - | |
| Hwa Jin Song Montesano | F | 53 | 4 anni | |
| Vivid Sehgal | M | 56 | 6 anni | |
| Brian Blakey | M | 61 | 6 anni | |
| Myra Rosario Herrle | M | - | 9 anni | |
| David Rowe | M | 57 | 20 anni | |
| Melissa Beelen | F | - | 12 anni | |
| John Lepore | M | - | 15 anni | |
| Dean Hakanson | M | 72 | 7 anni | |
| Nick Hirons | M | - | - | |
| Neil Pegg | M | - | - | |
| Alasdair James | M | 53 | 6 anni | |
| Michael Allen Luther | M | 67 | 15 anni | |
| James Wu | M | - | 10 anni | |
| Hu Li | M | 59 | 19 anni | |
| Gregg Brandyberry | M | - | 16 anni | |
| Lisa Bright | F | 56 | 17 anni | |
| Roger L. Hawley | M | 71 | 14 anni | |
| Steven Gelone | M | 56 | 2 anni | |
| Ronaldo Hermann Schmitz | M | 85 | 9 anni | |
| Ian Gilham | M | 64 | - | |
| Lucy Shapiro | M | 83 | 5 anni | |
| Martin Rosenberg | M | 78 | 5 anni | |
| Tamar Howson | F | 75 | 9 anni | |
| Howard H. Pien | M | 66 | 12 anni | |
| Paul W. Hawran | M | 71 | 9 anni | |
| George Poste | M | 79 | 7 anni | |
| Michael D. Rogers | M | 68 | 6 anni | |
| Geoffrey Nichol | M | 69 | 7 anni | |
| Joseph M. Spagnardi | M | 60 | 11 anni | |
| Riccardo Dalla-Favera | M | 72 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 6 anni |
| Leslie Hudson | M | 76 | 6 anni | |
| Charles Bramlage | M | 63 | 18 anni | |
| Maxine Gowen | M | 66 | 10 anni | |
| James R. Beery | M | 83 | 1 anni | |
| Robert Ruffolo | M | 74 | 16 anni | |
| Tim Tyson | M | 71 | 6 anni | |
| Argeris Karabelas | M | 71 | 6 anni | |
| Christoph Bruening | M | 56 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 7 anni |
| Scott Fields | M | 69 | 5 anni | |
| Douglas B. Snyder | M | 60 | 6 anni | |
| Lieven Nuyttens | M | 57 | 6 anni | |
| Eddie J. Gray | M | 64 | 12 anni | |
| Franco di Muzio | M | - | 8 anni | |
| Paul Carter | M | 63 | 10 anni | |
| Dean Mitchell | M | 68 | 15 anni | |
| Marc Rubin | M | 69 | 13 anni | |
| Jeff Baxter | M | 62 | 4 anni | |
| Peter Strong | M | - | 3 anni | |
| Gary Patou | M | 65 | 5 anni | |
| Jennie Younger | F | - | 5 anni | |
| Rupert Bondy | M | 62 | - | |
| Adrian Rawcliffe | M | 52 | 17 anni | |
| Lisa Porter | M | 60 | 5 anni | |
| Michael V. Milburn | M | - | 10 anni | |
| Don Soland | M | 65 | 9 anni | |
| Elaine Jones | M | 69 | - | |
| Donald Picker | M | 78 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 5 anni |
| Robert G. Pietrusko | M | 76 | 1 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Regno Unito | 93 | 93.00% |
| Stati Uniti | 7 | 7.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Randall K. Johnson
- Contatti personali
